Moors & Cabot, Inc. Neogenomics Inc Transaction History

Moors & Cabot, Inc.

$1.9 Billion
Q1 2025

A detailed history of Moors & Cabot, Inc. transactions in Neogenomics Inc stock. As of the latest transaction made, Moors & Cabot, Inc. holds 10,000 shares of NEO stock, worth $72,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,000

Holding current value

$72,800

% of portfolio

0.0%

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2025 May 08, 2025	BUY	$9.09 - $18.61 $90,900 - $186,100	10,000 New	10,000 $94,000
Q3 2021 Nov 05, 2021	BUY	$41.66 - $52.52 $833,199 - $1.05 Million	20,000 New	20,000 $23,000

Others Institutions Holding NEO

# of Institutions

288

Shares Held

127M

Call Options Held

942K

Put Options Held

172K

Black Rock Inc. New York, NY

19.7M
Shares

$143 Million
0.01% of portfolio
Vanguard Group Inc Valley Forge, PA

14.3M
Shares

$104 Million
0.0% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

6.72M
Shares

$48.9 Million
0.04% of portfolio
First Light Asset Management, LLC Edina, MN

6.04M
Shares

$44 Million
7.36% of portfolio
Janus Henderson Group PLC London, X0

5.74M
Shares

$41.8 Million
0.03% of portfolio

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $916M
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Moors & Cabot, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Moors & Cabot, Inc. with notifications on news.

Account